Health Catalyst Price to Book Ratio 2018-2024 | HCAT
Historical price to book ratio values for Health Catalyst (HCAT) over the last 10 years. The current price to book ratio for Health Catalyst as of November 11, 2024 is 1.42.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Health Catalyst Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2024-11-12 | 8.13 | 1.37 | |
2024-06-30 | 6.39 | $5.94 | 1.08 |
2024-03-31 | 7.53 | $6.06 | 1.24 |
2023-12-31 | 9.26 | $6.29 | 1.47 |
2023-09-30 | 10.12 | $6.70 | 1.51 |
2023-06-30 | 12.50 | $6.90 | 1.81 |
2023-03-31 | 11.67 | $7.26 | 1.61 |
2022-12-31 | 10.63 | $7.69 | 1.38 |
2022-09-30 | 9.70 | $8.12 | 1.20 |
2022-03-31 | 26.13 | $8.99 | 2.91 |
2021-12-31 | 39.62 | $9.92 | 3.99 |
2021-09-30 | 50.01 | $10.59 | 4.72 |
2021-06-30 | 55.51 | $6.05 | 9.18 |
2021-03-31 | 46.77 | $6.06 | 7.71 |
2020-12-31 | 43.53 | $6.37 | 6.84 |
2022-06-30 | 14.49 | $8.68 | 1.67 |
2020-09-30 | 36.60 | $7.09 | 5.16 |
2020-06-30 | 29.17 | $6.04 | 4.83 |
2020-03-31 | 26.15 | $5.39 | 4.85 |
2019-12-31 | 34.70 | $5.47 | 6.34 |
2019-09-30 | 31.64 | $5.66 | 5.59 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.506B | $0.296B |
Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Health Catalyst Inc. is based in Salt Lake City, Utah. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Tempus AI (TEM) | United States | $11.978B | 0.00 |
Inspire Medical Systems (INSP) | United States | $6.055B | 188.82 |
Hims & Hers Health (HIMS) | United States | $5.988B | 154.89 |
Axonics (AXNX) | United States | $3.602B | 1762.00 |
IRhythm Technologies (IRTC) | United States | $2.783B | 0.00 |
Privia Health (PRVA) | United States | $2.736B | 228.00 |
Enovis (ENOV) | United States | $2.646B | 17.94 |
Omnicell (OMCL) | United States | $2.263B | 74.03 |
Azenta (AZTA) | United States | $2.242B | 127.33 |
10x Genomics (TXG) | United States | $1.925B | 0.00 |
Clover Health Investments (CLOV) | United States | $1.657B | 0.00 |
Schrodinger (SDGR) | United States | $1.422B | 0.00 |
Phreesia (PHR) | United States | $1.252B | 0.00 |
Standard BioTools (LAB) | United States | $0.830B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.613B | 0.00 |
Talkspace (TALK) | United States | $0.586B | 0.00 |
Butterfly Network (BFLY) | United States | $0.582B | 0.00 |
Definitive Healthcare (DH) | United States | $0.508B | 88.00 |
Pulmonx (LUNG) | United States | $0.298B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
TruBridge (TBRG) | United States | $0.214B | 62.22 |
P3 Health Partners (PIII) | United States | $0.142B | 0.00 |
American Well (AMWL) | United States | $0.139B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.106B | 0.00 |
Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
HeartBeam (BEAT) | United States | $0.064B | 0.00 |
111 (YI) | China | $0.057B | 0.00 |
Zepp Health (ZEPP) | China | $0.050B | 0.00 |
Outset Medical (OM) | United States | $0.045B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
CareCloud (CCLD) | United States | $0.042B | 0.00 |
Movano (MOVE) | United States | $0.028B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
MSP Recovery (LIFW) | United States | $0.018B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
Precipio (PRPO) | United States | $0.009B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
Syra Health (SYRA) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Zhongchao (ZCMD) | China | $0.002B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |